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sadness and fatigue. She began to look for part-time work
but was hampered by low back pain. Complaints of financial
problems as well as anorexia and low energy re-emerged four
months prior to admission. She refused offers of psychological
counseling as well as free nutritional supplements.
Three months before this admission, her weight was 46 kg
and the serum albumin concentration was 2.6 g/dL. She was
referred to a psychiatrist who prescribed fluoxetine (Prozac).
A family conference was held the next month to address her
poor emotional and nutritional status. She was openly de-
pressed at the meeting.
Four weeks prior to this admission, she was admitted to
the hospital because of extreme fatigue. Her inpatient care
included enteral nutrition via a nasogastric feeding tube. She
was discharged after three weeks to a skilled nursing facility,
CASE PRESENTATION where she remained for one week before being readmitted to
A 57-year-old African American woman with end-stage re- the hospital with severe depression and failure to thrive.
nal disease (ESRD) due to diabetic nephropathy was admitted Her medical history was significant for hypertension for more
to the hospital for marked anorexia, weight loss, and fatigue. than 14 years, type 2 diabetes mellitus, and hypercholesterol-
These symptoms coincided with a depressed mood for a pro- emia. A total abdominal hysterectomy was performed 17 years
longed period. Four years prior to admission, hemodialysis for prior to admission. She had worked as a clerk for the U.S.
ESRD was started. After treatment with dialysis had com- Navy, and had been divorced several years prior to initiation
menced, she noted that her earlier feelings of sadness, anorexia,
of dialysis. Her medications were erythropoietin, calcium car-
and fatigue improved. She became a candidate for renal trans-
bonate, insulin, multivitamins, iron supplements, docusate so-plantation. Continuous ambulatory peritoneal dialysis (CAPD)
dium, calcitriol, sorbitol, lovastatin, lorazepam, famotidine, ci-was started 30 months prior to admission. Her weight and
sapride, and fluoxetine.height at that time were 64 kg and 5 feet 2 inches, respectively.
On admission to the hospital, her blood pressure was 115/85Citing “stress” in her life, the patient intermittently complained
mm Hg, her heart rate was 112 beats/min, and she weighedof forgetfulness, mild confusion, and anorexia during the first
45 kg. Physical examination revealed an emaciated but alert12 months she was treated with CAPD. She maintained her
woman in no apparent distress. She had mild peripheral neu-weight at 64 kg, and her serum albumin concentration remained
ropathy, but no other significant abnormalities were detected.in the range of 3.5 to 4.0 g/dL. Several episodes of peritonitis
Laboratory data on admission included a white blood cellduring the beginning of her second year of CAPD aggravated
count of 5300/mL; hematocrit, 25%; sodium, 131 mEq/L; potas-her feelings of sadness, frustration, and anxiety. By 12 months
prior to admission, her weight had fallen to 55 kg and her sium, 4.0 mEq/L; chloride, 105 mEq/L; bicarbonate, 21 mEq/L;
serum albumin concentration had dropped to 2.9 g/dL. BUN, 22 mg/dL; serum creatinine, 3.8 mg/dL; calcium, 3.7
Six months prior to this admission, the patient stated that mg/dL; phosphorus, 2.0 mg/dL; cholesterol, 153 mg/dL; protein,
her depressed mood and energy level were improving. She 3.6 g/dL; and albumin, 1.5 g/dL.
blamed personal and financial problems for her feelings of Upon admission she refused enteral feeding and any medical
therapy, including dialysis. A consulting psychiatrist found her
depressed yet able to make decisions regarding her medical
Key words: end-stage renal disease, stress, depression, social support, care. Several conferences among the medical, psychiatric, and
illness effects, marriage, family. renal teams along with the patient and her family took place
during the first week of admission. A joint decision was madeThe Nephrology Forum is funded in part by grants from Amgen,
Incorporated; Merck & Co., Incorporated; and Dialysis Clinic, Incorpo- to uphold the patient’s original wishes to forgo any active treat-
rated. ment of her physical condition. Supportive care to improve the
patient’s comfort was provided. She died on hospital day 19.Ó 2001 by the International Society of Nephrology
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DISCUSSION “allostasis,” the ability to achieve stability through
change [3]. “Allostatic load” refers to “the wear andDr. Paul Kimmel (Professor of Medicine, Division of
tear that the body experiences due to repeated cycles ofRenal Diseases and Hypertension, George Washington
allostasis as well as the inefficient turning-on and shut-University Medical Center, Washington, D.C.; and Direc-
ting-off of these responses [3].” Failure of levels of ator, Diabetic Nephropathy and HIV Programs, National
stress mediator to return to normal after a challenge alsoInstitute of Diabetes and Digestive and Kidney Diseases,
constitutes an abnormality of the allostatic system ofNational Institutes of Health, Bethesda, Maryland, USA):
stress responses [3]. Allostatic load (the physical effectWe recently celebrated the 20th anniversary of the Kid-
of stress) has been quantified in human studies by anney International “Nephrology Forum.” Another 20th
algorithm composed of various hemodynamic, biochemi-anniversary should be observed, however: that of the
cal and anthropometric measurements that can predictMarch 1980 Forum, “Emotional dehiscence after renal
a patient’s risk of developing cardiovascular disease, atransplantation,” in which Dr. Samuel H. Basch focused
decline in physical and cognitive function, and earlier-on a woman who had trouble adjusting to the stresses
than-expected mortality [3]. There can be variable end-of end-stage renal disease (ESRD). At the time, the
organ responses to increased allostatic load. The abilityliterature on the topic comprised only 18 references. To
of stress mediators to return to baseline is also a salientdate, most outcome data in ESRD patients have related
issue for patients with renal dysfunction. The manner into demographic and treatment correlates of survival,
which the response to changes in perception occurs inwhich are largely unmodifiable, but recently individual
different people is critical, as outcomes can be quiteinvestigators and the United States Renal Data System
variable in patients with similar allostatic loads. Age,(USRDS) have considered the effects of patients’ social
gender, presence of comorbid illness, developmental his-situation, perceptions and responses to the illness, physi-
tory, and genetic heterogeneity can contribute to differ-cians and dialysis unit staff, spouses and families, and
ent outcomes, but personality, mood, and habits andsocioeconomic status on outcomes. I will focus on pa-
behaviors (such as diet; level of exercise; use of tobacco,
tients treated with center hemodialysis, because they
alcohol, and regulated substances; and spiritual obser-
comprise the preponderance of patients with ESRD in vance) can alter the allostatic load as well. These re-
the United States, and the vast majority of the ESRD sponses can be thought of as “coping factors.” In addi-
patients over 65 years of age who seem most at risk tion, relationships among patients, physicians, and
for developing complications from depression [1, 2]. In dialysis staff; integration within a social network; educa-
contrast to the earlier Forum, I will not focus on individ- tion; occupation and financial status; and place of resi-
ual clinical issues in this review, but rather will discuss dence all might influence medical outcomes. Studies of
whether psychosocial factors affect outcomes, and assess stress have indicated that the two most important deter-
the nature of their biologic mediators. minants of outcome are the perceptions accompanying
Today’s patient started renal replacement therapy the stressor and the functional status of the subject [3].
with hemodialysis and later switched to continuous am- Stressors in the life of a dialysis patient can include
bulatory peritoneal dialysis (CAPD). While treated with dietary and time constraints, functional limitations, loss
a plethora of medications, including tranquilizers and of employment, changes in self-perception, alterations in
antidepressants, she exhibited symptoms of uremia, de- sexual function, general and perceived effects of illness,
pression, and malnutrition. No medical cause was evi- medications used to treat the illness, and fear of death.
dent for her downhill course. After a multidisciplinary The demands of ESRD treated with hemodialysis in-
evaluation found her to be depressed but capable of clude potential changes in a patient’s status in marital,
formulating her own health care plans, a joint patient/ familial, occupational, and societal contexts; the ex-
family/medical team consensus led to the decision to penses and worries associated with the treatment and
discontinue dialysis and provide only supportive care. the illness, and the uncertainty, anxiety, and costs en-
She died soon thereafter. Fundamental to understanding tailed while waiting for a transplant. In addition, treat-
this case are the constructs of stress and coping. ment within a unit implies a complex relationship with
The notion of stress has resisted definition since it was dialysis personnel: physicians, nurses, technicians, and
introduced in the 1930s by Hans Selye. Stress connotes other staff. Adaptive coping can produce desired out-
a change in the physical condition, environment, or psy- comes—full employment and successful function within
chosocial setting of an organism [3]. “Stress mediators,” a dyad and family. In the absence of such coping, disabil-
typically neurohumoral effectors of the central nervous ity and marital and family dysfunction can occur, as well
system or hypothalamic-pituitary-adrenal (HPA) axis, as depression, anxiety, loss of one’s role and identity,
are thought to have both protective and maladaptive and development or worsening of alcohol and substance
consequences, depending on the peak intensity and tim- abuse.
“Psychosocial parameters” include the vast number ofing of the response. Stress has been operationalized as
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psychologic variables and aspects of the social environ- chiatric Association outlined in the Diagnostic and Sta-
tistical Manual IV, major depressive disorder is diag-ment that affect all of us and are central to the patient’s
perception of quality of life [4]. The biopsychosocial nosed when a change from baseline occurs, lasting at
least two weeks, during which the patient experiencesmodel posits many intersecting levels of variables that
might determine overall health status, and which are either depressed mood or loss of interest in usual activi-
ties or anhedonia (the inability to experience pleasure)available for analysis. These parameters include individual
demographic data (age, ethnicity, gender), physiologic and at least five other symptoms of depression from a
group of nine, including depressed mood most of themeasures (body mass index; cardiovascular, immunologic,
and conditioning status), psychologic and behavioral pa- day, nearly every day; markedly diminished interest or
pleasure in most activities for most of the day; significantrameters (distress, personality factors, health-promoting
or -damaging habits), and social or environmental factors weight loss or gain, or appetite disturbance; insomnia or
hypersomnia; fatigue or loss of energy nearly every day;(for example, occupational imperatives, level of social
support, access to health care, residential characteristics, psychomotor agitation or retardation; feelings of worth-
lessness, or excessive or inappropriate guilt; diminishedand socioeconomic status). Patient-level psychosocial
parameters include personality factors, affect, and per- ability to think, concentrate, or be decisive; or recurring
thoughts of death, including suicidal ideation [9]. Dysthy-ceptions of distress, well-being, or illness; patient/spouse
indices include marital satisfaction; and patient/physi- mia is a chronic but milder depressive disorder, defined
by depressed mood present on more days than not forcian/dialysis staff measures include satisfaction with
health care, compliance with the dialysis regimen, and a period of two years and at least two of the symptoms
of depression, but not thoughts of death or suicide.level, number, and quality of interactions with personnel
and staff. Severe depression is characterized by disability, such
as an inability to function at work or do householdMuch of the information regarding psychosocial pa-
rameters in patients with renal disease is at the descrip- chores. The lifetime risk for major depressive disorder
in the general population is from 10% to 25% in womentive level, although some studies have correlated psy-
chosocial indices with physiologic or demographic and 5% to 12% in men; the point prevalence is from
5% to 9% in women and 2% to 3% in men [9]. Themeasures. Psychosocial factors might affect mortality
outcomes through at least four mechanisms: access to prevalence of depression is lowest in community sam-
ples, and progressively higher in outpatient and inpatienthealth care, compliance with the dialysis prescription or
medication regimen [5, 6], nutritional status, and neuro- settings [9]. Screening tools to assess depressive affect
include the Hamilton Rating Scale for Depression andendocrine or immunologic function [6, 7]. Today I will
consider seven factors that inform the lives of hemodialy- the Beck Depression Inventory (BDI) [9]. In subjects
without chronic illness, a BDI score , 9 suggests no orsis patients and the medical outcomes associated with
those factors. Specifically, I will look at depression, per- minimal depression, 10 to 18 represents mild to moderate
depressive affect, 19 to 29 is moderate to severe, andception of the burden of illness and social support, as
well as marital, familial, therapeutic, and residential and $30 indicates severe levels of depression [6], although
other rating systems have been employed.socioeconomic circumstances.
Although documentation from well-designed, large,
Depression epidemiologic studies is absent, depression is thought to
be the most common psychiatric abnormality in patientsThe World Health Organization forecasts that within
the next 20 years, depression will be the second most with ESRD treated with hemodialysis [6, 7, 13]. Depres-
sion can be a response to a loss [6], and ESRD patientscommon debilitating and economically costly illness
worldwide [8]. Compound depression, which occurs have sustained multiple losses, including loss of role
within the family and workplace, renal function and mo-when depression co-exists with another psychiatric or
medical illness [6, 9, 10], is characterized by a greater bility, physical skills, cognitive abilities, and sexual func-
tion. But a 1985 literature review noted that the preva-magnitude of depressive affect and is usually more resis-
tant to treatment. Depression is associated with in- lence of depression varied between zero and 100% in
studies of dialysis patients over the previous two decadescreased mortality in patients with acute myocardial in-
farction and in general medical inpatients [6, 10]. [14], suggesting that its true prevalence was unknown
and that the diagnosis of depression is highly dependentOne should not confuse the diagnosis of depression
with depressive effect or the symptoms of depression. A on the assessment tool used.
The prevalence of depression in outpatients withvariety of syndromes associated with depressive affect
have been described, including major depression and ESRD treated with hemodialysis is unknown. In a review
of hospitalization data from ESRD patients treated withdysthymia [9]. With few exceptions [11, 12], these disor-
ders have not been well studied in patients with renal dialysis in the U.S. in 1993, 8.9% were hospitalized with
a psychiatric diagnosis [15]. In 25% of these patients,disease. According to the criteria of the American Psy-
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the psychiatric diagnosis was the primary reason for the overlap between the symptoms of depression and those
of uremia [14]; this finding has been noted in otheradmission. The most common psychiatric disorders in
the population were depression and affective disorders chronic illnesses as well. The potential confounding be-
tween uremic and depressive symptoms makes research(26%), organic brain syndromes and dementia (26%),
schizophrenia and other psychoses (22%), and drug and in this chronically ill population difficult. But no overlap
exists between the symptoms of uremia and the thoughtsalcohol abuse (15%). Dialysis patients were more likely
than non-ESRD patients with ischemic heart disease or or cognitions accompanying depression: feelings of guilt
and worthlessness, preoccupation with thoughts of death,cerebrovascular disease to be hospitalized with a diagno-
sis of depression, but they had a risk of hospitalization and ideas and plans regarding suicide. Depressive symp-
toms thus can be characterized as either somatic or cogni-with depression equal to that of non-ESRD patients with
diabetes mellitus. Also, dialysis patients were more likely tive. To address the issue of whether the cognitive or
somatic aspects of depression are more important into be hospitalized with a psychiatric illness later in the
course of their ESRD. These findings suggest that these patients with renal disease, we devised the “Cognitive
Depression Index” (CDI) [17] by excluding those itemspsychiatric complications are not simply a consequence
of a short-term adjustment reaction to the regimen, but dealing with somatic symptoms from the BDI. Although
the CDI correlates highly with the BDI in our hemodialy-a long-term concomitant of coping with the chronic ill-
ness and its treatment. These data, however, identified sis patient population, except for early studies [17], the
CDI has not provided discriminative power in predictingpatients with the most severe psychologic and/or psychi-
atric disorders. outcomes [18, 19].
Few studies have assessed psychosocial factors in aLowry and Atcherson reported an 18% prevalence of
major depression, using American Psychiatric Associa- longitudinal manner or in relation to the stage of ESRD
or the course of the life cycle of an ESRD patient, antion criteria, in a group comprised mostly of white pa-
tients beginning home hemodialysis in Iowa [16]. Hin- important analytic control. In a 1987 longitudinal study,
Husebye et al showed that 42% of hemodialysis andrichsen et al found that 17.7% of prevalent center
hemodialysis patients satisfied criteria for minor de- peritoneal dialysis patients over the age of 70 had an
unchanged level of depression when reassessed after threepressive disorder, and 6.5% met criteria for a diagnosis of
major depression according to the Schedule for Affective years [20]. More than 25% of patients were less depressed
on re-evaluation, but almost 33% exhibited a higher levelDisorders and Schizophrenia [11]. Suicidal ideation and
depressed mood were the best discriminators among pa- of depressive symptoms. In our cross-sectional studies,
we found no relationship between the amount of timetients with major depression, minor depression, and
those without depression. that the patient had been treated for ESRD and the level
of depressive affect [19, 21]. Our longitudinal studies,Craven et al showed that a BDI score $15 had a 92%
diagnostic sensitivity and 80% specificity in making the however, revealed a tendency for levels of depression to
decrease over time [18]. This tendency reflects successfuldiagnosis of depressive disorder in patients with ESRD
treated with hemodialysis or peritoneal dialysis [12]. Al- patient adjustment to the stresses of ESRD but also a
potential consequence of survivor bias. Although meanthough the positive predictive value (39%) was much
lower than the negative predictive value (99%), diagnos- levels of depression tended to remain stable over time,
there was variation in individuals [18, 19].tic accuracy was high. Therefore, the investigators were
able to separate depressive symptoms from the psychiat- The possible interrelationships between depressive af-
fect and extent of compliance in patients with ESRDric disorder [12]. The cutoff score used in patients with-
out renal disease ($10) was associated with more false have not received much attention, and links between
these two parameters have been difficult to establish [5].negatives and a lower positive predictive value. They
showed that 45.4% of patients had depression as assessed Depression and other psychologic factors could influence
compliance and patient perceptions, including assess-by the BDI [12]. They also found that 8.1% of dialysis
patients (all of whom had been treated for more than ment of quality of life [4, 5, 7], and these perceptions
could possibly shorten patient survival. Everett and col-three months) had a major depressive disorder, and 6.1%
had a dysthymic disorder. In our studies of almost 300 leagues showed that stress was directly correlated with
increased interdialytic weight gain in hemodialysis pa-African American patients with ESRD treated with he-
modialysis in the Washington, D.C. area, 46.4% of pa- tients but noted that an increased patient perception of
depression was associated with less interdialytic weighttients had a BDI score . 10, 41.4% . 11, 34.6% . 13,
24.7% . 15, 15.6% . 19, and 3.7% . 30. Approximately gain for unknown reasons [22]. However, other studies
have been unable to delineate an association between5% were diagnosed with major depression, or were re-
ferred for psychiatric care (unpublished data). The mean depressive symptoms and compliance with fluid restric-
tion [5].BDI score in our population was 11.4 6 8.1.
Smith, Hong, and Robson pointed out the dramatic In our studies, increased depression was associated
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with increased serum phosphate concentration and with specific relationships in subgroups or in cohorts of pa-
tients who survive on dialysis for long periods.poor compliance with the dialysis prescription (unpub-
We previously highlighted the similarity of symptomslished data) [5, 21]. The magnitude of depressive affect
of depression and abnormal cytokine regulation such asdid not correlate with laboratory measures of compliance
fatigue, cognitive defects, and appetite and sleep distur-in patients beginning hemodialysis [23]. Incident patients
bances to those of uremia [reviewed in 28]. Cytokinewith higher levels of depressive affect, however, tended
dysregulation might be similar in patients with depres-to have poorer attendance at hemodialysis sessions (un-
sion and ESRD, and possibly provides a link betweenpublished data). Depressive affect also correlated with
the pathogenesis of symptoms in these two conditions.perception of the illness’ effects and inversely with per-
The end organ effects of circulating stress compounds,ceptions of satisfaction with life and social support. De-
as mediators of allostasis, which cannot return to physio-pression scores did not correlate with functional scores
logic levels because of failure of renal or dialytic clear-or severity of illness scores in patients beginning hemodi-
ance, are largely unknown in patients with renal disease.alysis [23]. In prevalent patients, however, increased dis-
Over the last 20 years, several studies assessed theability (but not severity of illness) correlated with in-
relationship between depression and mortality in hemo-creased depressive affect (unpublished data).
dialysis patients but reached contradictory conclusions.An extensive literature has linked depressive affect
Ziarnik and colleagues evaluated 47 center hemodialysisand disorders with immune dysfunction [reviewed in 6].
patients before they commenced renal replacement ther-Careful studies have shown that decreased cellular im-
apy. Because patients who died within one year hadmunity is present in unmedicated patients with depression
higher baseline depression scores than did the survivors,in the absence of chronic medical illness [24]. Depressed
they concluded that depression was an early mortalitypatients have higher circulating levels of interleukin-1
marker [30]. Wai and coworkers used discriminant ana-(IL-1) [25] and other acute-phase reactants [26] com-
lytic techniques to study 241 home hemodialysis patients,pared to control subjects; the same findings were ob-
and concluded that age, level of serum albumin, stress,tained in patients with ESRD [27]. Cytokines also might
and extent of depressive affect were different betweenbe markers for depression [reviewed in 28]. It is also
survivors and non-survivors at baseline [31]. A studynoteworthy that infusion of IL-1 produces side effects
of 167 home hemodialysis patients demonstrated thatsimilar to the symptoms of the uremic syndrome [re-
personality factors, in addition to age and depression,viewed in 28].
differentiated survivors and non-survivors [32]. In a pop-Friend and colleagues showed that increased levels of
ulation of 64 non-diabetic center and home hemodialysisdepression predicted the onset of diminution in serum
patients, those with BDI scores . 14 had significantly
albumin levels in hemodialysis and peritoneal dialysis
poorer survival rates [33]. Our own study of hemodialysis
patients with ESRD [29]. The reverse did not occur, and peritoneal dialysis patients revealed an association
implicating a primary role of depression in mediating between CDI scores and mortality [17].
medical outcomes. In our population, a higher level of These and other early studies, however, often failed
depressive affect also correlated with lower serum albu- to use appropriate sophisticated statistical techniques to
min concentrations in prevalent patients (unpublished account for variation in potential confounding variables
data). In preliminary studies of 295 maintenance hemodi- and mortality risk factors such as age, race, gender, co-
alysis patients, increased BDI and CDI scores (signifying morbid conditions, nutritional markers and status, and
increased levels of depressive affect) correlated with lev- dose of dialysis. In addition, studies were typically per-
els of the immune markers, total hemolytic complement formed on small cross-sections of hemodialysis groups
and T-cell function. Also, BDI scores correlated with without control for the time since patients had started
levels of circulating IL-1 (unpublished data). These me- renal replacement therapy for ESRD and in the absence
diators are associated with mortality in hemodialysis pa- of longitudinal follow-up. Finally, most studies reported
tients [27, 28]. level of depressive affect assessed at the convenience of
We recently demonstrated an association between in- the interviewer, and not at the time of a signal event in
creased levels of depressive affect and higher b-endor- the patient’s emotional life or medical course, or at the
phin levels in female African American hemodialysis time of diagnosis of depression.
patients [28]. Depression can be a particularly potent In contrast to these earlier studies, several more recent
stressor in female hemodialyis patients, causing physio- and better-designed studies have failed to demonstrate
logic stimulation of the autonomic nervous system. These an association between depression and survival in hemo-
data suggest different relationships between depression dialysis patients. Devins et al studied 97 hemodialysis,
and medical mediators, depending on duration of dialysis peritoneal dialysis, and transplant patients and could
and on gender. Such differences might provide clues not discern an association between depressive affect and
mortality over approximately four years [34]. Husebyeregarding adaptation and coping, or they could represent
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Table 1. Therapeutic options for patients with depression with an individual class of drugs are of paramount impor-
tance in choosing therapy; this relates both to the poten-Antidepressant drugs
Older agents tial of discontinuation due to unpleasant symptoms and
First-generation tricyclic antidepressants the problems associated with specific physiologic compli-Second-generation tricyclic antidepressants
cations in medically ill patients, such as orthostatic hypo-Heterocyclic antidepressants
Monoamine oxidase inhibitors tension and cardiac arrythmias with therapy using the
Newer agents tricyclic antidepressants in dialysis patients. SertralineSelective serotonin release inhibitors (SSRIs)
(Zoloft), a selective serotonin release inhibitor, and flu-Serotonin reuptake inhibitors
Noradrenaline reuptake inhibitors oxetine (Prozac), a serotonin reuptake inhibitor, im-
Selective norepinephrine reuptake inhibitors prove orthostatic hypotension in hemodialysis patients,Reverse inhibitors of monoamine oxidase
perhaps by direct effects on autonomic tone mediated5-hydroxy-tryptophan2 receptor antagonists
5-hydroxy-tryptophan1a receptor agonists by serotonin [36, 37]. The dose of tricyclic antidepres-
Dopamine reuptake inhibitors sants must be carefully titrated during therapy. The ther-Dopamine antagonists
apeutic dose for selective serotonin release inhibitors isHerbal and alternative remedies (such as St. John’s wort)
Psychotherapy usually the starting dose. Both classes of drugs are
Electroconvulsive therapy cleared by the liver, and therefore usually no dose adjust-
ment is necessary for decreased renal function in the
absence of hepatic disease. Patients should be treated
for at least six weeks before an evaluation is made re-
and colleagues studied 78 hemodialysis and CAPD pa- garding the outcome of therapy. Concurrent supportive
tients more than 70 years of age but could not show a psychotherapy can be useful, as this approach can in-
relationship between depressive affect and mortality crease efficacy and decrease the relapse rate [9].
[20]. Christensen and colleagues also were unable to Few studies have evaluated therapy for depression in
show an association of level of depressive affect and patients with chronic renal failure. Streltzer treated five
survival in 78 primarily white hemodialysis patients fol- hemodialysis patients who had major depressive epi-
lowed for 7 to 60 months, although age and BUN pre- sodes with tricyclic antidepressants. Three had an excel-
dicted early mortality [35]. We also did not discern an lent response but two did not respond [38]. Kennedy,
association between depression and mortality using Cox Craven and Roin treated 8 of 10 hemodialysis and perito-
regression techniques in a population of 295 mostly Afri- neal dialysis patients who had major depressive episodes
can American, urban hemodialysis patients, when varia- with desipramine or, in one case, mianserin [39]. Six
tions in age, medical comorbidity, dialyzer type, and level patients completed the trial, and five recovered from
of albumin were controlled [19]. their depressive syndrome. Blumenfield and colleagues
In the longitudinal phase of our study, as many as six performed a randomized, double-blind, placebo-con-
sequential assessments of depressive affect were made trolled study of fluoxetine in 14 patients with major de-
[18]. After a median follow-up period of a little more pression and ESRD treated with hemodialysis [40]. No
than three years, we were, however, able to demonstrate patient discontinued treatment because of side effects.
that a one standard deviation increase in depression Patients treated with fluoxetine had improvement in de-
score evaluated over time was associated with an 18% pression scores after four weeks, but differences could
to 32% increased risk of mortality when variations in not be demonstrated from baseline values after eight
other risk factors were controlled. weeks of therapy [40].
Options for treating depression consist of pharmaco- In an innovative study, Friend and colleagues demon-
therapy, psychotherapy, and electroconvulsive therapy, strated that participation in a group therapy session in
alone or in combination (Table 1) [9]. First- and second- the dialysis unit was associated with significantly im-
generation tricyclic antidepressants, selective serotonin proved survival in urban patients [41]. Although this was
release inhibitors, serotonin and noradrenaline reuptake not a randomized controlled study, and it potentially
inhibitors, monoamine oxidase inhibitors and reverse in- suffers from selection biases, it provides important theo-
hibitors of monoamine oxidase, 5-hydroxy tryptophan2 retical and practical bases for further studies. Institution
receptor antagonists, and herbal and alternative reme- of an exercise program at a Greek hemodialysis center
dies (such as St. John’s wort) have all been used and was associated with a dramatic improvement of affect
evaluated in the treatment of depression in patients with- of patients, with the most severely depressed patients
out coexistent medical illness [9]. There is no evidence benefiting most from the intervention [42]. Although
that the serotonin release inhibitors confer an advantage changes might have been in the somatic rather than cog-
over the tricyclic antidepressants for treatment of major nitive aspects of depression, exercise might still be a
depression in patients without concurrent serious medi- worthwhile supplemental therapy that has few, if any,
deleterious side effects in selected patients.cal illness [9]. Therefore the side effect profiles associated
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Suicide, the gravest complication of depression, dis- and greater satisfaction with their health and more satis-
proportionately affects older white men in the U.S. Pa- faction with their lives than did elderly white dialysis
tients with ESRD can display suicidal behavior differ- patients [48]. These findings are important if perception
ently, and perhaps attempt and commit suicide more of illness is associated with clinical outcomes, because
easily than non-medically ill populations, by noncompli- cognition might be amenable to modification through
ance with the dialysis regimen or by manipulation of counseling or psychotherapy. Perception of fewer effects
their hemoaccesses [6, 43]. In a landmark paper, Neu of illness correlated with better attitudes towards compli-
and Kjellstrand reported a 9% incidence of withdrawal ance, greater perceived family support, and lower levels
from dialysis, which accounted for 22% of deaths of the of stress [5, 7, 21].
presumably primarily white ESRD patients in their study Medical and demographic factors such as age, severity
[44]. Of 1,766 patients over 13.5 years old, 3 clearly com- of co-morbid medical illness, and anthropometric mea-
mitted suicide; the investigators suggested that this rate sures did not correlate with perception of illness effects
was approximately 15 times greater than that in the gen- in our patient population, yet feelings that their illness
eral population. The prevalence of suicide varies among interfered with their lives were associated with lower
ethnic groups, with African Americans having a rela- levels of circulating total hemolytic complement and with
tively low suicide rate [45]. Most patients who withdraw increased levels of circulating IL-1 in our group of 295
from dialysis are elderly or have diabetes [1, 44]. Death hemodialysis patients (unpublished data).
from suicide occurred at a rate of approximately 0.2% Perception of illness intrusiveness was not associated
per 1,000 dialysis patient years [1]. Medical complica- with behavioral compliance measures in our studies [5].
tions and failure to thrive are the most common causes We also have been unable to show that more severe medi-
for withdrawal [1]. Withdrawal rates were two to three cal illness leads to lower levels of perceived social support
times greater in white compared to Asian, Native Ameri- or to a decreased perception of well-being [19]. Patients’
can, or black patients in any age category [1]. The rela- perceptions of increased illness intrusiveness were asso-
tionship of antecedent depression to withdrawal and sui- ciated with poorer survival in our patient population
cide has been poorly delineated. [19]. Shulman et al also found a higher mortality rate in
patients with perception of greater illness [33]. Self-ratedPerception of the burden of illness
health status and satisfaction with life indices were asso-
Perception of the burden of illness is defined as pa- ciated with survival in univariate analyses in older hemo-
tients’ assessment of how the disease interferes with their dialysis patients, but were not associated with survival
lives in personal, social, familial, and occupational con- when controlled for the level of functional status [49].
texts [4, 7, 46]. Patients with the same medical diagnoses
can have divergent views regarding the intrusive effects Social support
of their illness, depending on age, gender, ethnic and
Social support is the perception that an individual iscultural background, personality, and extent of social
a member of a complex network in which one can givesupport or marital satisfaction. The existence of other
and receive affection, aid, and obligation [50]. Socialmedical problems, for example, congestive heart failure,
support can be received from family members, friends,angina, recent surgery, or infection, also can modify pa-
pastors, acquaintances in the workplace, and medicaltients’ perceptions of illness. Perception of illness is likely
personnel, and is well recognized as an important factoran important aspect of coping with or adjustment to
in the patient’s adjustment to chronic and acute illnesschronic illness.
[35, 50, 51]. Social support has been consistently linkedPatients’ perception of their well-being, an important
to improved health outcomes in numerous studies fromcomponent of quality of life, is easily assessed and forms
the U.S. and abroad as well as in populations with varyingan important part of the medical evaluation [4, 46, 47].
chronic illnesses characterized by different geographicPerception of effects of illness can differ at different
settings, socioeconomic status, and ethnic backgroundsstages of the hemodialysis patient’s course and is not
[50]. In fact, differences in social support among groupsnecessarily linked with objective medical indicators, such
have been suggested as accounting for differences in theas measures of functional status. Appraisal of burden of
mortality rate of dialysis patients among units [52] orillness is associated with measurements of general well-
among national populations [19], and possibly are re-being, happiness, depression, and social support, and
sponsible for differences in compliance [5, 53]. Althoughwith levels of neuroendocrine and immune mediators.
the relationships are consistent and robust, the mecha-Assessment of the burdensome nature of an illness
nisms underlying the connection between social supportalso can be related to patient expectations and cultural
and illness have not been clearly delineated [50, 54].factors, and can vary among patients of different ages.
Candidates for mediators between social support andElderly African American dialysis patients experienced
fewer symptoms, lesser perception of effects of illness, improved health include better access to and utilization
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of health care; better compliance; and better psychologic, support received from friends correlated inversely with
neuroendocrine mediators associated with mortality, andneuroendocrine, or immunologic function [19, 50, 54].
Several studies have shown an association between positively with mediators associated with survival (un-
published data). These findings suggest that patients’survival and perception of social support in ESRD pa-
tients of different ethnic backgrounds [19, 20, 35, 55, 56]. friends play a unique role during the course of dialysis.
In one prospective study, a quality-of-life measure that
Marital issuesincluded social support predicted survival of hemodialy-
sis patients [55]. In another study, family cohesion as a Relations with an intimate partner can either have
positive aspects, such as associations with greater per-measure of social support predicted survival [35]. The
effects of medical and treatment parameters such as nu- ceived social support, or negative ones, associated with
hostility. Marital stability, satisfaction and perceptionstritional status, delivery and intensity of dialysis, and
patient compliance were not controlled in these studies, of hostility have been associated with differential health
outcomes in the general population [reviewed in 28].however. Further, patients’ assessment of giving social
support predicted improved survival in hemodialysis pa- Unhappily married individuals report poorer health than
do happily married or divorced people with similar de-tients [56]. We showed that increased perception of social
support predicted survival when variation in age, severity mographic characteristics. Marital conflict can affect per-
ceptions of illness and interfere with the ability of aof comorbid illness, level of serum albumin, dialysis
membrane type, and study site were controlled [19]. patient to comply with the complex dialysis regimen.
Declines in reported marital satisfaction have been asso-High levels of social support have been associated
with increased utilization of medical services [50]. Social ciated with subsequent poorer health evaluations.
Chronic illness in a member of a dyad can radicallysupport has been associated with compliance of ESRD
patients treated with hemodialysis [5, 7, 19, 23], although change marital roles. Spouses can become caregivers
and, regardless of role, can experience depression, hostil-the findings have been variable and partly depend on
the parameters assessed in different populations. Hemo- ity, or both. In addition, the spouse can be the object of
the patient’s negative emotions. Finally, sexual dysfunc-dialysis patients who perceived substantial family sup-
port had lower levels of interdialytic weight gain and tion can alter the dynamics of the relationship. Few stud-
ies exist on spousal or family relations in ESRD patients,better biochemical compliance measures [51]. A large
study using USRDS data found that patients who did not and almost none focus on outcomes [58–61]. In one early
study, more than 50% of couples that included a patientlive alone were less likely to shorten their hemodialysis
treatments [57]. However, the study noted no association with ESRD experienced marital disruption [58]. Another
study highlighted a correlation between patients’ andbetween household composition and attendance at he-
modialysis sessions, interdialytic weight gain, or serum spouses’ BDI scores [61]. A study of 68 Israeli prevalent
hemodialysis patients and their spouses revealed highphosphate level. Indirect indices of social support and
measures of social adjustment were associated with levels of distress compared with normative groups, and
high correlations between distress scores of spouses [59].greater interdialytic weight gain in studies in Israel and
the United Kingdom [5]. Moreover, other studies either Although a high prevalence of sexual dysfunction af-
fected home dialysis patients, their marital and socialcould not establish relationships between measures of
social support from family and friends and compliance adjustment scores were comparable to those of the gen-
eral population [62].in hemodialysis patients [5] or found a correlation of
greater perception of social support with worsened com- Dyadic conflict has been associated with endocrino-
logic and immunologic responses in women, but not men,pliance [5]. We found no correlation of social support
measures and standard laboratory compliance measures. in subjects without renal disease [63]. Strong negative
emotion, such as perception of dyadic conflict, can be aIn contrast, perception of total social support and social
support received from friends was correlated with im- particularly important stressor in women ESRD patients,
activating physiologic and neuroendocrine pathways.proved attendance at scheduled dialysis sessions (unpub-
lished data) [5]. Indices of social support correlated with Negative effect within a marital dyad sometimes is a
stronger predictor of long-term marital satisfaction andlevel of depressive symptoms, perception of illness ef-
fects, and satisfaction with life in our studies [19]. stability than is positive emotional exchange. The giving
and receiving of social support within a marriage alsoWe noted an interesting correlation between levels of
circulating b-endorphin and total perceived social sup- can change during the course of ESRD. In Canadian
couples with one ESRD patient, women patients per-port from friends, but not from other individual sources
of social support in incident patients (unpublished data). ceived that family support declined after the onset of
illness. No change in perceived support was noted byLevels of circulating IL-12 were inversely related to the
level of perceived total support and support received male ESRD patients [60].
We studied the interrelationships among medical fac-from friends in 75 such patients. In prevalent patients,
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tors, neuroendocrine and immunologic factors, and out- alone, or only with a spouse or partner. Complex house-
holds were defined as patients living with various combi-come in 174 male and female hemodialysis patients in
dyadic relationships [28]. Higher levels of depressive af- nations of relatives and non-relatives, often in multigen-
erational groups. After a three-year observation period,fect and increased perception of the burden of illness
correlated with increased severity of illness and with Cox regression analyses revealed that only age of the
patient and household structure were associated withhigher circulating levels of IL-1 and b-endorphin, but
these effects were only evident in women in the study. survival rates. Patients who lived in complex families
had a significantly increased relative risk of mortality,Marital satisfaction and conflict scores correlated with
medical risk factors, psychosocial parameters, and circu- but again, the differences among women were largely
responsible for the overall findings [68]. These data sug-lating IL-1 and b-endorphin levels, but again, only in
women. Neuroendocrine, immunologic, and marital indi- gest that African American women with ESRD treated
with hemodialysis and living in complex households orces predicted differential survival in the study group, but
the dyadic indices were associated with outcome only in in difficult marital situations are at particular risk for
early death. This risk likely relates to the patient’s expec-the women.
tations of and coping with family duties; many of these
Family issues patients have limited economic resources and/or dimin-
ished social support. Previous studies have indicated thatFew data exist regarding family structure, relation-
ships, and function in dialysis patients, or assessing out- stress, inflammatory responses, and depressive symp-
toms are more common and more intense in womencome in patients within compared with those outside a
family unit. Although some studies have evaluated fam- than in men; perhaps these responses are mediated by
estradiol and differential activation of components ofily responses to home hemodialysis, the findings are often
in groups too small to control for multiple demographic, the HPA system [reviewed in 3, 28, 63].
Few studies have addressed the association of psy-socioeconomic, medical, and treatment variables. Al-
most no data link these factors with physiologic measures chosocial and socioeconomic parameters, such as family
closeness, income and education of the family, and rela-or ESRD patient outcomes. Families may be a source
of social support or of stress. Fathers of pediatric patients tionships with the dialysis unit staff, with outcome. In
a prospective, multicenter study of African Americanwith ESRD reported higher stress, depression, and anxi-
ety than did the mothers [64]. These findings were more hemodialysis patients and their families, we used a family
problem-solving task, measures of family closeness, fam-pronounced in parents of older children. Using a proce-
dure for coding family interaction, Steidel et al demon- ily composition, and income to assess family function.
We also evaluated patient “closeness” to the dialysisstrated that family cohesion was associated with better
patient compliance with dialysis regimens [65]. Poor unit personnel. In contrast to what we expected to find,
patient closeness to family, closeness to the dialysis unitcompliance in pediatric ESRD patients was associated
with poor adjustment of their parents [66]. Family struc- staff, and greater family resources predicted earlier mor-
tality. Patient closeness to family was a stronger predictorture and socioeconomic status also were associated with
patient compliance. In a study of 74 urban African Amer- of patient mortality in families with better problem-solv-
ing skills, higher incomes, and more complex composi-ican hemodialysis patients and their families, we noted
that better family coordination predicted better patient tions (abstract; Leidner et al, J Am Soc Nephrol, 11:
1244A, 2000). The mechanisms underlying these associa-compliance with the dialysis prescription (unpublished
data) [5]. Reiss and coworkers conducted a pilot study tions are unclear, but the stress of hemodialysis might
play a more destructive role in close knit, accomplishedof 23 urban hemodialysis patients in families and found
paradoxical relationships between factors usually consid- families, or in treatment settings that place high time or
emotional demands on patients.ered strengths and hemodialysis patients’ survival [67].
Surprisingly, patients who were more compliant in fami-
Relationships with dialysis personnellies functioning as integrated groups had higher mortality
rates. The authors concluded that ESRD in a patient The dialysis unit and staff might play an important role
in determining outcomes, but few studies have addressedwas a greater stress for organized families. They specu-
lated that patients in vulnerable families bonded to the this issue. McClellan and colleagues showed that un-
measured dialysis unit characteristics predicted survivaldialysis unit by exhibiting increasing compliance with
the medical regimen. better than traits delineated by differences in the case
mix [52]. We found that groups of dialysis unit staffWe recruited almost 500 families of African American
hemodialysis patients in Washington and Philadelphia exhibit specific characteristics over time despite a high
turnover rate of individual employees; this stability sug-for studies of family function and outcome. Families were
categorized according to size and structure. A simple gests that a “culture” typifies each particular dialysis
unit [69]. Few studies have evaluated the relationshiphousehold was defined as one in which the patient lived
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between patients’ feelings about the dialysis staff and during ESRD. Differences between outcomes of ESRD
patients in different countries should be assessed; theseoutcomes. In a subset of our population, we asked pa-
tients about their level of satisfaction with their nurses, studies should account for variations in family structure,
social structure, and extent of perceived social support.technicians, and nephrologists. Patients’ increased satis-
faction with staff and their perception that staff cared Stress mediators should be evaluated at baseline and
longitudinally in studies of patients with ESRD in whichabout them correlated with higher serum albumin levels.
Patients’ increased satisfaction with physicians, but not morbidity and mortality are outcomes.
Patients with ESRD treated with hemodialysis dealnursing or technical personnel, correlated with improved
attendance and greater total time compliance with the with the multiple stressors of their illness and attempt
to cope with the demands of their spouses, families, occu-dialysis prescription (abstract; Kimmel et al, J Am Soc
Nephrol 9:1092A, 1998). Dialysis unit staff characteristics pations, and communities. A tremendous amount has
been learned about the physiologic reactions of dialysisalso were associated with varying patient compliance, as
assessed by biochemical indices [5]. Patients’ interactions patients. The field of stress has just begun to make plausi-
ble connections between emotions and their biologic me-with staff as well as dialysis unit characteristics likely
are important factors in mediating outcomes in dialysis diators. End-stage renal disease represents the para-
digmatic chronic disease. Our patients are available forprograms with similar patient populations. In addition,
the role of physicians and dialysis corporations responsi- study on a consistent basis, and standard biochemical
markers that are related to outcome are easily obtainedble for the organization of dialysis units should be ex-
plored further. and measurable. Nephrologists and their patients can
contribute to a broader understanding of stress by eluci-
Residential and socioeconomic issues dating the connections between psychosocial variables
on the one hand and physiologic, endocrinologic, andResidence, a key factor of socioeconomic status, as
well as the location of the dialysis unit might contribute neuroimmunologic variables on the other.
to outcome of patients with ESRD. Not enough study We should ask for our patients’ own assessments of
has been devoted to the notion that varying quality of how they are doing, what their relationships are like in
physician care likely characterizes programs in different their marriages and families, and what life is like in their
neighborhoods. Two studies have linked lower socioeco- neighborhoods. Then we should carefully listen to their
nomic status to an increased incidence of ESRD [70, 71]. answers. Our patients’ stories might be telling us as much
Although few groups have investigated the relationship about their mortality risk as their serum albumin concen-
between survival and socioeconomic status in the ESRD tration does. The time is ripe for interventions in the field
population, Port et al demonstrated that higher socioeco- of depression, social support, and patients’ perceptions
nomic status was associated with improved survival in regarding their illnesses. I am sure that we can provide
ESRD patients from Michigan [72]. But in preliminary data by performing such studies that will be crucial in
investigations using a larger database, we found a para- improving the quality and length of our patients’ lives.
doxical association (abstract; Kimmel et al, J Am Soc
Nephrol, 11:1236A, 2000). Patients living in areas with
QUESTIONS AND ANSWERShigher socioeconomic status in the U.S. had poorer out-
Dr. Norman Levy (Adjunct Professor of Medicine andcomes, but these effects were limited to minority popula-
Clinical Professor of Psychiatry, SUNY Health Sciencestions. The reasons for this finding are unclear but possibly
Center at Brooklyn, New York): Do you see any connec-reflect different allocation of resources among groups in
tion between anemia and depression? Is having 40%the same residential area, different access to health care
fewer red blood cells a factor that augments or precipi-and services, discordance between viewpoints of physi-
tates depression? My second question is, although wecians and patients, or subtle effects of discrimination
know that the patient was given fluoxetine, we don’t[45]. Minority populations in the ESRD program appear
know whether she took it or what its effects were. Anti-to be at risk from inequitable distribution of resources.
depressants are effective in 60% of all patients, so oneTo differing extents, psychosocial function might be re-
often tries another antidepressant if the first doesn’tlated to socioeconomic status, in part as a result of per-
work. I assume another drug wasn’t used. Finally, didception of stress [73].
you consider whether this patient’s refusal to accept dial-
Conclusions ysis was an outcome of a suicidal intent, which was a
result of depression?Few studies have tracked psychosocial responses lon-
Dr. Kimmel: Few data have associated level of depres-gitudinally in patients treated for ESRD and linked these
sion and hematocrit in cross-sectional studies of dialysisresponses with outcome. Almost no data exist regarding
patients. We have analyzed data from 300 patients andexamining psychosocial factors in patients with chronic
renal insufficiency which predict subsequent outcome found no relationship between level of depressive affect
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and hematocrit. Data suggest that if anemia is corrected extent of T-cell function and number, would be evident.
We ended up not being able to demonstrate many suchat the beginning of dialysis, quality-of-life indicators im-
prove as the hematocrit increases over time [74]. But no relationships. The timing of analyses might be crucial in
demonstrating such relationships, however.one has determined that once the hematocrit has increased
to approximately 35%, further increases are associated Dr. Alan Christensen: (Associate Professor of Psy-
chology and Internal Medicine, University of Iowa, Iowawith improvement in quality-of-life indicators.
I think this patient gave up in the middle of her treat- City, Iowa): If we want to understand the association of
some of these psychosocial factors and outcomes, wement. I don’t know whether her course represented a
vicious cycle of medical illness, which increased the in- must understand the underlying causal mechanisms. We
know from some of your work and others’ that dialysistensity and morbidity of depression and in turn exacer-
bated the medical illness (which is what I think occurred), patients are immunocompromised and that immune de-
ficiency is related to earlier mortality. Depressed patientsor whether another event supervened. Perhaps this pa-
tient didn’t take the antidepressant drugs that we pre- are immunocompromised, as are patients with low social
support. No one has determined whether the differencesscribed, just as she might not have taken many of the
drugs that would have improved her laboratory values. we see in mortality rate as a function of depression are
due to immunologic differences. How might we under-We had a fairly dramatic family meeting, where the psy-
chiatric team decided that the patient was rational and stand better the causal relationships that link changes in
psychosocial factors with outcomes?capable of making decisions, although she was severely
depressed. The psychiatric and medical teams, the fam- Dr. Kimmel: We need to perform longitudinal studies
to establish causal and temporal relationships. Dr. Friendily, and the patient believed that her medical status was
so poor that the attempt to gain weight and recover has addressed this issue, relating a decline in albumin
concentration to subsequent development of depressionphysical function was either useless or not worth the
effort, since her perceived quality of life had declined [29]. Our own studies taught us that multiple longitudinal
evaluations are important in establishing causal relation-to the point where a rational person might decide to
stop living. We tried to manage the discontinuation of ships [18]. If we could measure the stress mediators and
psychosocial variables concurrently, repeatedly overdialysis in the hospital, where the patient was given sup-
portive and comfort care. This approach, termed provid- time, we could begin to determine temporal relationships
as well. Finally, the best way to establish causal relation-ing a “good death,” can be achieved in hemodialysis
patients [75]. ships is to perform an interventional trial.
Dr. Ronald Friend (Professor of Psychology, StateBut you raise an extremely important issue. Early data
suggested that the suicide rate in dialysis patients was University of New York, Stony Brook, New York): We
performed a correlational observation study, not an in-100 to 400 times greater than that in the general popula-
tion, and that dialysis noncompliance gave patients an tervention [29]. At time one, we measured serum albu-
min and depression using the BDI, and then we mea-easy mechanism for committing suicide [43]. I think we
are more aware of the problem now. The current suicide sured these parameters a second time. We therefore
determined that increased depressive affect at time onerate in patients with ESRD is much lower than it was
20 years ago [1]. But it is possible that although the predicted decreases in serum albumin concentrations
across time. The reverse did not occur.suicide rate has decreased, the withdrawal rate might be
higher. Whether withdrawal is a form of suicide is a hotly Dr. Judith Veis (Attending Physician, Washington
Hospital Center, Washington, D.C.): I am concerneddebated issue. Dr. Cohen at Baystate Medical Center
believes that it is not [75], but many nephrologists do about the ability of social workers to focus on the psy-
chosocial aspects of care and to improve our patients’perceive withdrawal as a treatment failure and suicide.
Dr. Joseph Vassalotti (Associate Professor, Mount social support and satisfaction with life. Our social work-
ers should focus more on these aspects, rather than insur-Sinai School of Medicine, New York, New York): Admin-
istration of a-interferon, used in the treatment of chronic ance and transportation issues, which consume a lot of
their time. Have any social support interventions beenviral infections and certain cancers, has been associated
with depression [76]. Could you comment on the rela- successful in other chronic illnesses?
Dr. Kimmel: Although not designed for dialysis pa-tionship between depression and immune function in
dialysis patients? tients, some social support interventions have focused
on lower socioeconomic groups [77]. Educational groupsDr. Kimmel: The relationship between depression and
b-endorphins and IL-1 in married African American meet once each week for six weeks and deal with con-
crete issues such as “How one accesses health care sys-women is compelling. The original hypothesis of our
study of 300 hemodialysis patients was that relationships tems,” or “How one assesses employment opportuni-
ties.” Although those are models for rehabilitation orbetween psychosocial factors and physiologic markers,
including levels of cortisol and selected cytokines, and employment, they provide social support and enhance
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coping skills, and are therefore worth considering in pa- until they started dialysis. The two groups had equivalent
levels of serum creatinine at baseline. The nephrologiststients with ESRD.
Dr. Rolf Peterson (Professor, Department of Psychol- were unaware of the enhanced-intervention class. We
measured how much patients knew about renal failureogy, George Washington University, Washington, D.C.):
I think probably the best model that we have at the and its treatment before and after our educational inter-
ventions to make sure that the intervention produced amoment is the effect of a social support intervention in
patients with breast cancer [78, 79]. Provision of social change in knowledge. Patients in the control group who
received the standard education started dialysis a mediansupport definitely affects not only quality of life, but
length of life. of six months after randomization. Patients in the experi-
mental group who received enhanced education startedDr. Christensen: Speigel et al performed a random-
ized study of provision of social support in breast cancer dialysis a median of 12 months after randomization [81].
Not only did gains in knowledge correlate with extensionpatients [78]. The support was provided by the group
itself and was coupled with hypnosis and other kinds of of the pre-dialysis interval, but patients in our experi-
mental group continued to know much more about theactivities. Those who received the social support inter-
vention survived for about three years on average, while disease and its treatment four and one-half years after
starting dialysis.in the control group, patients survived a little more than
half as long. Dr. Kimmel: Can you speculate on the mediators of
this extraordinarily dramatic biologic effect?Dr. Gerald Devins (Professor of Psychiatry and Psy-
chology, University of Toronto, Toronto, Ontario): You Dr. Devins: We are concluding a second study, of 300
patients, in which we hope to replicate this phenomenonsaid that you believe the patient had given up, and that
her health deteriorated after that. There has been a lot and to test some mechanisms that might account for
it. One mechanism might be that increased knowledgeof interest lately in pre-dialysis interventions. Would you
speculate about these options in this patient and for renal lessens the unpredictability of the patient’s illness and
thus helps control distress and anxiety. This mechanismfailure patients generally?
Dr. Kimmel: This patient had progressed far beyond even might improve blood pressure, an important factor
in mediating the progression of renal failure.the stage of chronic renal insufficiency. She had survived
for a long time with end-stage renal disease. Actually We also have been evaluating nutritional intake. Do
patients alter their diets after educational intervention?she had been excited about starting dialysis while staying
employed at her job. But disincentives made her contin- The patients in our experimental group commented that
they were going to change their dietary behavior as aued employment difficult.
In studies performed with Dr. Peterson, we compared result of the educational intervention. We also speculate
that social support might be an element of the educa-patients with chronic renal insufficiency and patients
with ESRD [80]. The level of depressive affect in a small tional intervention.
Dr. Susie Q. Lew (Professor of Medicine, Georgegroup of patients with chronic renal insufficiency was
higher than that in a group of CAPD and hemodialysis Washington University Medical Center): You mentioned
that depressed patients can be helped with intervention.patients. The patients with chronic renal insufficiency
were evaluated when they were about to have their vas- Did any patients in your study receive medication or
other therapy [18]? Did their biochemical or psychoso-cular access procedures, so I think it was a time fraught
with anxiety for them. Further studies must be performed cial factors change in any way?
Dr. Kimmel: We had a stop point in this study at whichon individual patients through the course of their chronic
renal insufficiency and ESRD to establish patterns of patients who had very high BDI levels were evaluated
by a psychiatrist for suicidal tendencies. Those patientsadjustment. If we could ameliorate the morbidity of
chronic renal insufficiency, we could lower costs and comprised a very small number, about 15 in 300. We
haven’t analyzed them separately.perhaps improve the outcomes of ESRD. Dr. Devins,
you used an educational intervention in patients with Dr. Robert Star (National Institute of Diabetes and
Digestive and Kidney Diseases, National Institutes ofchronic renal insufficiency and dramatically improved
outcomes. Can you tell us about the study? Health, Bethesda, Maryland): I have noticed that a com-
munity of patients forms within the dialysis unit itself. IDr. Devins: We identified people at the point of transi-
tion from chronic renal insufficiency to progressive renal think this is particularly true in units where the chairs
are very close together. Are there variations in the preva-failure, when the serum creatinine concentration was
,350 mm/L (3.9 mg/dL). We gathered 204 patients from lence of depression or other psychosocial dysfunction in
different dialysis units? Could group therapy take placeseveral hospitals in Montreal and Calgary and random-
ized them to standard education or enhanced-education during dialysis? Patients are dialyzed for perhaps 15
hours a week, and that time could be used constructively.interventions. The latter was a presentation delivered
one on one by a psychologist. The patients were followed Dr. Kimmel: I’ll answer the second question first. Yes,
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